CEA being a common serum marker, its serum levels in patients with lung cancer (30.19 ± 9.64 ng/ml) were higher than those in healthy volunteers (2.20 ± 2.47 ng/ml, P < 0.001) (Figure 4A). The gene discussed is CEACAM5; the disease is lung carcinoma.